People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Scynexis Inc | — | Pharmaceuticals | Series A | $22.7M | $354.6M | 2011 |
Yves J. Ribeill at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Yves J. Ribeill on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ann F. Hanham | 1 | 3 |
| Pamela J. Kirby | 1 | 1 |
| Jean-Yves F. Nothias | 1 | 1 |
| Jose F. Barella | 1 | 1 |
| Mounia F. Chaoui | 1 | 1 |
| Ed J. Penhoet | 1 | 1 |
| Laurent F. Arthaud | 1 | 1 |
| Charles F. Osborne, Jr. | 1 | 1 |
| Patrick J. Langlois | 1 | 1 |
| Brian J. Schwab | 1 | 1 |
| Horace D. Nalle | 1 | 1 |
| Mounia D. Chaoui | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.